NCT01443338

Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2

A Phase4,Multicenter, Randomized,Double-blind,Double Dummy, Parallel Controlled Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Treatment of Chinese Patients With Moderate to Severe Psoriasis Vulgaris

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 720 (estimated)
• Sponsor: Ministry of Health, China · Other Government
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether Triptergium wilfordii, and Acitretin are effective and safe in the treatment of patient of moderate to severe psoriasis vulgaris.

Conditions

• Psoriasis Vulgaris

Interventions

Type	Name	Description
DRUG	Triptergium Wilfordii	Tablet,10mg/Tab,20mg Tid,No more than 8 Weeks
DRUG	Acitretin	Capsule,10mg/Cap,30mg Qd,no more than 8 weeks

Timeline

• Start date: 2011-09-01
• Primary completion: 2012-12-01
• First posted: 2011-09-29
• Last updated: 2011-09-29

Locations

1 site across 1 country: China